Attend the FierceBiotech Executive Breakfast at BIO 2019
Join us on June 5th for our panel discussion on real-world evidence. Reserve your seat today.
A drugmaker working on generic sterile injectables has opened a manufacturing facility in South Florida.
Amid China's tighter grip on antibiotics use, Lilly sold Chinese rights to two legacy antibiotics and a manufacturing facility to China's Eddingpharm.
What challenges continue to plague the pharmaceutical industry for almost a decade? Check out this remarkable innovation in glass science that may be the…
Alvogen is recalling two lots of mismarked fentanyl patches because they could lead to overdoses.
The recall from the U.S. of tainted blood pressure medicines reached new heights as India’s Torrent Pharmaceuticals recalled 104 lots of losartan.
WuXi Biologics says its plant in Wuxi, China, has gotten the go-ahead from the FDA to make HIV drug Trogarzo for TaiMed Biologics.
As a key global ingredient supplier, problems in China can ripple worldwide as they have for Swiss CDMO Lonza.
The FDA found unacceptable levels of bacteria in the water system of a U.S. maker of over-the-counter meds, including for infants and children.
A Lithuanian CDMO is investing €50 million in its biologics manufacturing site and adding up to 80 jobs.
Chinese CDMO GenScript Biotech has started construction on a production facility to specialize in plasmids and viruses manufacturing.
Smoke from a fire set off by welding sparks reportedly killed 10 workers and injured a dozen rescuers at a pharmaceutical plant in China.
